Epigenetic blood biomarkers of cellular and replicative senescence may improve the clinical assessment of COPD patients, particularly for those at a higher risk of deathhttps://bit.ly/3nEM7tp
No takes yet. Share an insight, caveat, or question.
Cordero et al. (2021) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: